Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05038943 · ClinicalTrials.gov registry record · NA
Evaluation of Safety and Effectiveness of The SherpaPak in Donation After Circulatory Death Heart Transplantation
A NA study, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT05038943 is a NA study that has completed, run by University of Nebraska. The registered enrollment target is 5 participants.
The verdict
NCT05038943, a NA study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This is a prospective, pilot trial to evaluate the safety and effectiveness of The Paragonix SherpaPak™ Cardiac Transport System ("SherpaPak CTS") in transportation of cardiac allografts recovered from donors after circulatory death with thoracoabdominal normothermic regional perfusion (TA-NRP). SherpaPak™ CTS is an ultraportable hypothermic preservation and transport system that has been approved by United States Food \& Drug Administration (FDA) for clinical use in heart transplantation.
Interventions
- DEVICE Paragonix SherpaPak Cardiac Transport System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2021-09-15 |
| Est. Completion | 2022-04-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05038943
The ClinicalTrials.gov registry entry for NCT05038943 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Paragonix SherpaPak Cardiac Transport System is the first listed.
NCT05038943 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05038943 about?
NCT05038943 is a clinical study titled "Evaluation of Safety and Effectiveness of The SherpaPak in Donation After Circulatory Death Heart Transplantation". This is a prospective, pilot trial to evaluate the safety and effectiveness of The Paragonix SherpaPak™ Cardiac Transport System ("SherpaPak CTS") in transportation of cardiac allografts recovered from donors after circulatory death with thoracoabdominal normothermic regional perfusion (TA-NRP). She...
What is the current status of trial NCT05038943?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2021-09-15. Estimated completion is 2022-04-08.
What interventions are being tested in trial NCT05038943?
The interventions under investigation include: Paragonix SherpaPak Cardiac Transport System (DEVICE).
Who is sponsoring clinical trial NCT05038943?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.